156 related articles for article (PubMed ID: 21336381)
1. LIPS arrays for simultaneous detection of antibodies against partial and whole proteomes of HCV, HIV and EBV.
Burbelo PD; Bren KE; Ching KH; Gogineni ES; Kottilil S; Cohen JI; Kovacs JA; Iadarola MJ
Mol Biosyst; 2011 May; 7(5):1453-62. PubMed ID: 21336381
[TBL] [Abstract][Full Text] [Related]
2. Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems).
Burbelo PD; Ching KH; Mattson TL; Light JS; Bishop LR; Kovacs JA
Biochem Biophys Res Commun; 2007 Jan; 352(4):889-95. PubMed ID: 17157815
[TBL] [Abstract][Full Text] [Related]
3. Immunization With Fc-Based Recombinant Epstein-Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model.
Zhao B; Zhang X; Krummenacher C; Song S; Gao L; Zhang H; Xu M; Feng L; Feng Q; Zeng M; Xu Y; Zeng Y
Front Immunol; 2018; 9():932. PubMed ID: 29765376
[TBL] [Abstract][Full Text] [Related]
4. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
Zhu QY; Kong XW; Sun C; Xie SH; Hildesheim A; Cao SM; Zeng MS
mSphere; 2020 Dec; 5(6):. PubMed ID: 33268566
[TBL] [Abstract][Full Text] [Related]
5. A Luciferase Immunoprecipitation System (LIPS) assay for profiling human norovirus antibodies.
Tin CM; Yuan L; Dexter RJ; Parra GI; Bui T; Green KY; Sosnovtsev SV
J Virol Methods; 2017 Oct; 248():116-129. PubMed ID: 28673856
[TBL] [Abstract][Full Text] [Related]
6. Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies.
Burbelo PD; Issa AT; Ching KH; Exner M; Drew WL; Alter HJ; Iadarola MJ
Virol J; 2009 May; 6():45. PubMed ID: 19409090
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
8. Detection of IgG directed against a recombinant form of Epstein-Barr virus BALF0/1 protein in patients with nasopharyngeal carcinoma.
Shao Z; Borde C; Marchand CH; Lemaire SD; Busson P; Gozlan JM; Escargueil A; Maréchal V
Protein Expr Purif; 2019 Oct; 162():44-50. PubMed ID: 31145974
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antibodies to the Epstein-Barr virus immediate early gene product ZEBRA by a new enzyme-linked immunosorbent assay.
Yamauchi Y; Tachiband Y; Maeda A; Wakiguchi H; Usui M; Kurata T; Sairenji T
Intervirology; 1998; 41(6):278-84. PubMed ID: 10325538
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
[TBL] [Abstract][Full Text] [Related]
11. Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS).
Burbelo PD; Ching KH; Klimavicz CM; Iadarola MJ
J Vis Exp; 2009 Oct; (32):. PubMed ID: 19812534
[TBL] [Abstract][Full Text] [Related]
12. The split Renilla luciferase complementation assay is useful for identifying the interaction of Epstein-Barr virus protein kinase BGLF4 and a heat shock protein Hsp90.
Wang J; Guo W; Long C; Zhou H; Wang H; Sun X
Acta Virol; 2016 Mar; 60(1):62-70. PubMed ID: 26982469
[TBL] [Abstract][Full Text] [Related]
13. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.
Coghill AE; Bu W; Nguyen H; Hsu WL; Yu KJ; Lou PJ; Wang CP; Chen CJ; Hildesheim A; Cohen JI
Clin Cancer Res; 2016 Jul; 22(14):3451-7. PubMed ID: 26920891
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.
Lang D; Vornhagen R; Rothe M; Hinderer W; Sonneborn HH; Plachter B
Clin Diagn Lab Immunol; 2001 Jul; 8(4):747-56. PubMed ID: 11427421
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome.
Liu Z; Coghill AE; Pfeiffer RM; Proietti C; Hsu WL; Chien YC; Lekieffre L; Krause L; Yu KJ; Lou PJ; Wang CP; Mulvenna J; Middeldorp JM; Bethony J; Chen CJ; Doolan DL; Hildesheim A
J Infect Dis; 2018 May; 217(12):1923-1931. PubMed ID: 29509907
[TBL] [Abstract][Full Text] [Related]
16. Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis.
Mueller NE; Lennette ET; Dupnik K; Birmann BM
Int J Cancer; 2012 Jun; 130(12):2886-91. PubMed ID: 21805472
[TBL] [Abstract][Full Text] [Related]
17. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
[TBL] [Abstract][Full Text] [Related]
18. Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays.
Bian X; Wallstrom G; Davis A; Wang J; Park J; Throop A; Steel J; Yu X; Wasserfall C; Schatz D; Atkinson M; Qiu J; LaBaer J
Diabetes; 2016 Jan; 65(1):285-96. PubMed ID: 26450993
[TBL] [Abstract][Full Text] [Related]
19. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
20. Schizophrenia is Associated With an Aberrant Immune Response to Epstein-Barr Virus.
Dickerson F; Jones-Brando L; Ford G; Genovese G; Stallings C; Origoni A; O'Dushlaine C; Katsafanas E; Sweeney K; Khushalani S; Yolken R
Schizophr Bull; 2019 Sep; 45(5):1112-1119. PubMed ID: 30462333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
